Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Sibilia

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Molecular & Cellular Oncology|June 17, 2016
Mechanisms underlying skin disorders induced by EGFR inhibitorsMartin Holcmann, Maria Sibilia
Methods in Molecular Biology (Clifton, N.J.)|September 3, 2010
Methods to study MAP kinase signalling in the central nervous systemBettina Wagner, Maria Sibilia
International Journal of Molecular Sciences|January 6, 2016
EGFR Signaling in Liver DiseasesKarin Komposch, Maria Sibilia
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2007
The EGF receptor is required for efficient liver regenerationAnuradha Natarajan, Bettina Wagner, Maria Sibilia
Oncoimmunology|December 25, 2012
How imiquimod licenses plasmacytoid dendritic cells to kill tumorsMartin Holcmann, Barbara Drobits, Maria Sibilia
Metabolites|March 24, 2022
Lipid Metabolism Interplay in CRC-An UpdateDana Krauß, Ourania Fari, Maria Sibilia
Trends in Endocrinology and Metabolism: TEM|October 13, 2009
The EGFR network in bone biology and pathologyMarlon R Schneider, Maria Sibilia, Reinhold G Erben
The Journal of Investigative Dermatology|July 6, 2016
Effects of Imiquimod on Hair Follicle Stem Cells and Hair Cycle ProgressionNicole Amberg, Martin Holcmann, Gabriel Stulnig, et al.
Journal of Neuroinflammation|May 22, 2026
The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversationKatharina Gryksa, Maria Sibilia, Veit Rothhammer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimodFrancesca Palamara, Simone Meindl, Martin Holcmann, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Molecular & Cellular Oncology|June 17, 2016
Mechanisms underlying skin disorders induced by EGFR inhibitorsMartin Holcmann, Maria Sibilia
Methods in Molecular Biology (Clifton, N.J.)|September 3, 2010
Methods to study MAP kinase signalling in the central nervous systemBettina Wagner, Maria Sibilia
International Journal of Molecular Sciences|January 6, 2016
EGFR Signaling in Liver DiseasesKarin Komposch, Maria Sibilia
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2007
The EGF receptor is required for efficient liver regenerationAnuradha Natarajan, Bettina Wagner, Maria Sibilia
Oncoimmunology|December 25, 2012
How imiquimod licenses plasmacytoid dendritic cells to kill tumorsMartin Holcmann, Barbara Drobits, Maria Sibilia
Metabolites|March 24, 2022
Lipid Metabolism Interplay in CRC-An UpdateDana Krauß, Ourania Fari, Maria Sibilia
Trends in Endocrinology and Metabolism: TEM|October 13, 2009
The EGFR network in bone biology and pathologyMarlon R Schneider, Maria Sibilia, Reinhold G Erben
The Journal of Investigative Dermatology|July 6, 2016
Effects of Imiquimod on Hair Follicle Stem Cells and Hair Cycle ProgressionNicole Amberg, Martin Holcmann, Gabriel Stulnig, et al.
Journal of Neuroinflammation|May 22, 2026
The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversationKatharina Gryksa, Maria Sibilia, Veit Rothhammer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimodFrancesca Palamara, Simone Meindl, Martin Holcmann, et al.
Pageof 12